FDA Personnel Growth Could Have Plateaued For Drugs Program
This article was originally published in The Tan Sheet
Executive Summary
Only a handful of new FTEs are requested in President Obama’s FY 2016 budget request for human drugs activities, suggesting that GDUFA and other related programs may have reached their critical mass of employees for now.
You may also be interested in...
FDA’s Rent Is Too Damn High: Consolidated Labs Cost More Than Off-Campus Space
After moving thousands of employees from leased off-campus space to the new Life Sciences-Biodefense Laboratory at its White Oak headquarters, FDA is paying 23% more in rent.
FDA Field Operations Would Endure Reductions Under Budget
President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.
Show Me The Money: FDA Recruitment Efforts Challenged By Government Salaries
FDA’s Center for Drugs continues to operate under a staffing shortage at a time when it faces tremendous pressure to implement new authorities. In some cases, that’s left Janet Woodcock scrambling to find senior managers that can lead top CDER initiatives. Direct hiring authority has helped, but it doesn’t fully address FDA’s recruiting challenges. There’s still too much red tape – and not enough money.